rs10590816
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_001291867.2(NHS):c.216_218delGCC(p.Pro73del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00632 in 1,071,997 control chromosomes in the GnomAD database, including 297 homozygotes. There are 1,744 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001291867.2 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NHS | NM_001291867.2 | c.216_218delGCC | p.Pro73del | disruptive_inframe_deletion | Exon 1 of 9 | ENST00000676302.1 | NP_001278796.1 | |
NHS | NM_198270.4 | c.216_218delGCC | p.Pro73del | disruptive_inframe_deletion | Exon 1 of 8 | NP_938011.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NHS | ENST00000676302.1 | c.216_218delGCC | p.Pro73del | disruptive_inframe_deletion | Exon 1 of 9 | NM_001291867.2 | ENSP00000502262.1 | |||
NHS | ENST00000380060.7 | c.216_218delGCC | p.Pro73del | disruptive_inframe_deletion | Exon 1 of 8 | 1 | ENSP00000369400.3 |
Frequencies
GnomAD3 genomes AF: 0.0324 AC: 3570AN: 110092Hom.: 153 Cov.: 21 AF XY: 0.0289 AC XY: 951AN XY: 32952
GnomAD3 exomes AF: 0.00377 AC: 186AN: 49359Hom.: 5 AF XY: 0.00276 AC XY: 49AN XY: 17765
GnomAD4 exome AF: 0.00333 AC: 3202AN: 961861Hom.: 144 AF XY: 0.00256 AC XY: 786AN XY: 307081
GnomAD4 genome AF: 0.0325 AC: 3577AN: 110136Hom.: 153 Cov.: 21 AF XY: 0.0290 AC XY: 958AN XY: 33006
ClinVar
Submissions by phenotype
not specified Benign:3
- -
- -
- -
Inborn genetic diseases Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Nance-Horan syndrome Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at